MeiraGTx Holdings plc

MGTX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
129
SEC Filings

Business Summary

PARTI Overview We are a vertically integrated, clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including radiation-induced xerostomia, Parkinsons disease and AIPL1-associated retinal dystrophy. Our clinical programs use targeted local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet need. The successful development of the clinical pipeline is supported by our internal end-to-end manuf...

Next Earnings

Q2 FY2026 — expected 2026-08-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMGTXdiscussed_in_filing Artificial Intelligence
topic_mentionMGTXdiscussed_in_filing Cybersecurity
topic_mentionMGTXdiscussed_in_filing Trusted Computing
topic_mentionMGTXdiscussed_in_filing Blockchain & Crypto
topic_mentionMGTXdiscussed_in_filing Regulation
topic_mentionMGTXdiscussed_in_filing Healthcare & Bio
topic_mentionMGTXdiscussed_in_filing Platform & Ecosystem
topic_mentionMGTXdiscussed_in_filing Artificial Intelligence
topic_mentionMGTXdiscussed_in_filing Cybersecurity
topic_mentionMGTXdiscussed_in_filing Trusted Computing
topic_mentionMGTXdiscussed_in_filing Blockchain & Crypto
topic_mentionMGTXdiscussed_in_filing Regulation
topic_mentionMGTXdiscussed_in_filing Healthcare & Bio
topic_mentionMGTXdiscussed_in_filing Platform & Ecosystem
topic_mentionMGTXdiscussed_in_filing Artificial Intelligence
topic_mentionMGTXdiscussed_in_filing Cybersecurity
topic_mentionMGTXdiscussed_in_filing Trusted Computing
topic_mentionMGTXdiscussed_in_filing Blockchain & Crypto
topic_mentionMGTXdiscussed_in_filing Regulation
topic_mentionMGTXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001104659-26-036494EDGAR121K words
2025-03-132024-12-310001558370-25-002867EDGAR
2024-03-152023-12-310001558370-24-003309EDGAR
2023-03-142022-12-310001558370-23-003674EDGAR
2022-03-102021-12-310001558370-22-003302EDGAR
2021-03-112020-12-310001558370-21-002773EDGAR
2020-03-112019-12-310001558370-20-002429EDGAR
2019-03-262018-12-310001193125-19-086735EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001104659-25-110898EDGAR74K words
2025-08-142025-06-300001558370-25-011512EDGAR
2025-05-132025-03-310001558370-25-007498EDGAR
2024-11-132024-09-300001558370-24-015444EDGAR
2024-08-122024-06-300001558370-24-011788EDGAR
2024-05-092024-03-310001558370-24-007477EDGAR
2023-11-142023-09-300001558370-23-018916EDGAR
2023-08-102023-06-300001558370-23-014416EDGAR
2023-05-112023-03-310001558370-23-009274EDGAR
2022-11-102022-09-300001558370-22-017417EDGAR
2022-08-112022-06-300001558370-22-013192EDGAR
2022-05-122022-03-310001558370-22-008452EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001104659-26-034904EDGAR5K words
2026-01-020001104659-26-000068EDGAR
2025-11-130001104659-25-110883EDGAR
2025-11-100001104659-25-108804EDGAR
2025-08-140001558370-25-011478EDGAR
2025-06-260001558370-25-008870EDGAR
2025-06-170001558370-25-008676EDGAR
2025-05-130001558370-25-007497EDGAR
2025-05-090001558370-25-007074EDGAR
2025-04-040001558370-25-004490EDGAR

129 total filings indexed. 99 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001735438
TickerMGTX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: cf09805117a62d7ea4443aa66f05891188d29556c6c6c3ebef6f2077ce89f11a
parent: 9bbff337be63d7fe273faf27264d2a9ac16ee75f583727ec0619c7825973ec3d
content hash: 61c3711d2aebb4ba345df0406cecf50336314a3db2ff93b24e0a822d104f06e0
signed: 2026-04-13T04:46:15.486Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf